InvestWiki
Sign in
TMO

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Expands Offerings Via New Agreements and Market Growth

·Consolidated from 5 sources

Thermo Fisher Scientific is positioned for growth in several key market segments, including magnetic beads and Grignard reagents. The company has also entered a new reseller agreement and announced its upcoming earnings conference call.

Thermo Fisher Scientific is set to participate in the expanding global cell line generation market, which is projected to reach USD 2.67 billion by 2032, driven by advancements in AI, CRISPR technology, and automation. Reports indicate a compound annual growth rate of 10.86% for this sector, with Thermo Fisher Scientific among the key players advancing innovation.

The company is also a significant contributor to the magnetic beads market, a sector expected to surge from USD 3.3 billion in 2025 to USD 7.4 billion by 2032. Thermo Fisher Scientific is competing with other major entities like Merck KGaA and QIAGEN for leadership in this expanding field, according to strategic business reports.

Further opportunities are noted in the Grignard reagents market, which is forecasted to reach USD 7.87 billion by 2032. This growth is attributed to safer, AI-enabled production methods, with Thermo Fisher Scientific alongside Merck KGaA and Tokyo Chemical Industry identified as key participants.

In recent business developments, Thermo Fisher Scientific has entered into a reseller agreement for Evosep's Eno product. The company also announced that it will hold its earnings conference call on Wednesday, October 21, 2026, providing investors with an update on its financial performance and strategic outlook.

0 0 0Sign in to react

Sources

This recap was generated by consolidating the public headlines below.